Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Maryam Asgari to Risk Factors

This is a "connection" page, showing publications Maryam Asgari has written about Risk Factors.

 
Connection Strength
  
 
 
1.503
  
  1. Kim Y, Yin J, Le Breton S, Jorgenson E, Huang H, Choquet H, Asgari MM. Genetically Predicted Serum Vitamin C Levels and Cutaneous Squamous Cell Carcinoma Risk. J Invest Dermatol. 2023 04; 143(4):664-667.
    View in: PubMed
    Score: 0.083
  2. Jorgenson E, Choquet H, Yin J, Hoffmann TJ, Banda Y, Kvale MN, Risch N, Schaefer C, Asgari MM. Genetic ancestry, skin pigmentation, and the risk of cutaneous squamous cell carcinoma in Hispanic/Latino and non-Hispanic white populations. Commun Biol. 2020 12 14; 3(1):765.
    View in: PubMed
    Score: 0.073
  3. Kim Y, Zhang F, Su K, LaRochelle M, Callahan M, Fisher D, Wharam JF, Asgari MM. Perioperative Serum 25-Hydroxyvitamin D Levels as a Predictor of Postoperative Opioid Use and Opioid Use Disorder: a Cohort Study. J Gen Intern Med. 2020 09; 35(9):2545-2552.
    View in: PubMed
    Score: 0.070
  4. Chavez A, Quesenberry CP, Darbinian J, Asgari MM. Association of Valproic Acid Use, a Potent Histone Deacetylase Inhibitor, and Melanoma Risk. J Invest Dermatol. 2020 12; 140(12):2353-2358.
    View in: PubMed
    Score: 0.070
  5. Neugebauer R, Su KA, Zhu Z, Sokil M, Chren MM, Friedman GD, Asgari MM. Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A?cohort study. J Am Acad Dermatol. 2019 Apr; 80(4):998-1005.
    View in: PubMed
    Score: 0.063
  6. Kim Y, Blomberg M, Rifas-Shiman SL, Camargo CA, Gold DR, Thyssen JP, Litonjua AA, Oken E, Asgari MM. Racial/Ethnic Differences in Incidence and Persistence of Childhood Atopic Dermatitis. J Invest Dermatol. 2019 04; 139(4):827-834.
    View in: PubMed
    Score: 0.063
  7. Wang W, Ollila HM, Whittemore AS, Demehri S, Ioannidis NM, Jorgenson E, Mignot E, Asgari MM. Genetic variants in the HLA class II region associated with risk of cutaneous squamous cell carcinoma. Cancer Immunol Immunother. 2018 Jul; 67(7):1123-1133.
    View in: PubMed
    Score: 0.061
  8. Jorgenson E, Choquet H, Yin J, Asgari MM. Common Mitochondrial Haplogroups and Cutaneous Squamous Cell Carcinoma Risk. Cancer Epidemiol Biomarkers Prev. 2018 07; 27(7):838-841.
    View in: PubMed
    Score: 0.061
  9. Sordillo JE, Kraft P, Wu AC, Asgari MM. Quantifying the Polygenic Contribution to Cutaneous Squamous Cell Carcinoma Risk. J Invest Dermatol. 2018 07; 138(7):1507-1510.
    View in: PubMed
    Score: 0.060
  10. Asgari MM, Chien AJ, Tsai AL, Fireman B, Quesenberry CP. Association between Lithium Use and?Melanoma Risk and Mortality: A?Population-Based Study. J Invest Dermatol. 2017 10; 137(10):2087-2091.
    View in: PubMed
    Score: 0.057
  11. Yesantharao P, Wang W, Ioannidis NM, Demehri S, Whittemore AS, Asgari MM. Cutaneous squamous cell cancer (cSCC) risk and the human leukocyte antigen (HLA) system. Hum Immunol. 2017 Apr; 78(4):327-335.
    View in: PubMed
    Score: 0.056
  12. Ray GT, Kulldorff M, Asgari MM. Geographic Clusters of Basal Cell Carcinoma in a Northern California Health Plan Population. JAMA Dermatol. 2016 11 01; 152(11):1218-1224.
    View in: PubMed
    Score: 0.055
  13. Asgari MM, Toland AE, Arron ST. IRF4 Polymorphism Is Associated with Cutaneous Squamous Cell Carcinoma in?Organ Transplant Recipients: A Pigment-Independent Phenomenon. J Invest Dermatol. 2017 01; 137(1):251-253.
    View in: PubMed
    Score: 0.054
  14. Asgari MM, Warton EM, Whittemore AS. Family history of skin cancer is associated with increased risk of cutaneous squamous cell carcinoma. Dermatol Surg. 2015 Apr; 41(4):481-6.
    View in: PubMed
    Score: 0.049
  15. Asgari MM, Warton EM, Quesenberry CP, Koralek DO, Taylor M. Risk of subsequent cutaneous squamous cell carcinoma in patients with melanoma. J Am Acad Dermatol. 2014 Sep; 71(3):521-8.
    View in: PubMed
    Score: 0.046
  16. Silverberg MJ, Leyden W, Warton EM, Quesenberry CP, Engels EA, Asgari MM. HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer. J Natl Cancer Inst. 2013 Mar 06; 105(5):350-60.
    View in: PubMed
    Score: 0.042
  17. Asgari MM, Brasky TM, White E. Association of vitamin A and carotenoid intake with melanoma risk in a large prospective cohort. J Invest Dermatol. 2012 Jun; 132(6):1573-82.
    View in: PubMed
    Score: 0.040
  18. Asgari MM, Chren MM, Warton EM, Friedman GD, White E. Supplement use and risk of cutaneous squamous cell carcinoma. J Am Acad Dermatol. 2011 Dec; 65(6):1145-51.
    View in: PubMed
    Score: 0.038
  19. Asgari MM, White E, Warton EM, Hararah MK, Friedman GD, Chren MM. Association of tea consumption and cutaneous squamous cell carcinoma. Nutr Cancer. 2011; 63(2):314-8.
    View in: PubMed
    Score: 0.037
  20. Asgari MM, Chren MM, Warton EM, Friedman GD, White E. Association between nonsteroidal anti-inflammatory drug use and cutaneous squamous cell carcinoma. Arch Dermatol. 2010 Apr; 146(4):388-95.
    View in: PubMed
    Score: 0.034
  21. Asgari MM, Efird JT, Warton EM, Friedman GD. Potential risk factors for cutaneous squamous cell carcinoma include oral contraceptives: results of a nested case-control study. Int J Environ Res Public Health. 2010 02; 7(2):427-42.
    View in: PubMed
    Score: 0.034
  22. Asgari MM, Tang J, Warton ME, Chren MM, Quesenberry CP, Bikle D, Horst RL, Orentreich N, Vogelman JH, Friedman GD. Association of prediagnostic serum vitamin D levels with the development of basal cell carcinoma. J Invest Dermatol. 2010 May; 130(5):1438-43.
    View in: PubMed
    Score: 0.034
  23. Asgari MM, Maruti SS, Kushi LH, White E. Antioxidant supplementation and risk of incident melanomas: results of a large prospective cohort study. Arch Dermatol. 2009 Aug; 145(8):879-82.
    View in: PubMed
    Score: 0.033
  24. Asgari MM, Tang J, Epstein EH, Chren MM, Warton EM, Quesenberry CP, Go AS, Friedman GD. Statin use and risk of basal cell carcinoma. J Am Acad Dermatol. 2009 Jul; 61(1):66-72.
    View in: PubMed
    Score: 0.033
  25. Asgari MM, Maruti SS, Kushi LH, White E. A cohort study of vitamin D intake and melanoma risk. J Invest Dermatol. 2009 Jul; 129(7):1675-80.
    View in: PubMed
    Score: 0.032
  26. Asgari MM, Maruti SS, White E. A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence. J Natl Cancer Inst. 2008 Jul 02; 100(13):967-71.
    View in: PubMed
    Score: 0.031
  27. Asgari MM, Kiviat NB, Critchlow CW, Stern JE, Argenyi ZB, Raugi GJ, Berg D, Odland PB, Hawes SE, de Villiers EM. Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals. J Invest Dermatol. 2008 Jun; 128(6):1409-17.
    View in: PubMed
    Score: 0.030
  28. George CD, Lee T, Hollestein LM, Asgari MM, Nijsten T. Global epidemiology of actinic keratosis in the general population: a systematic review and meta-analysis. Br J Dermatol. 2024 03 15; 190(4):465-476.
    View in: PubMed
    Score: 0.023
  29. Choquet H, Ashrafzadeh S, Kim Y, Asgari MM, Jorgenson E. Genetic and environmental factors underlying keratinocyte carcinoma risk. JCI Insight. 2020 05 21; 5(10).
    View in: PubMed
    Score: 0.017
  30. Roberts MR, Asgari MM, Toland AE. Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet? Br J Dermatol. 2019 12; 181(6):1146-1155.
    View in: PubMed
    Score: 0.016
  31. Nagarajan P, Asgari MM, Green AC, Guhan SM, Arron ST, Proby CM, Rollison DE, Harwood CA, Toland AE. Keratinocyte Carcinomas: Current Concepts and Future Research Priorities. Clin Cancer Res. 2019 04 15; 25(8):2379-2391.
    View in: PubMed
    Score: 0.016
  32. Wang W, Jorgenson E, Ioannidis NM, Asgari MM, Whittemore AS. A Prediction Tool to Facilitate Risk-Stratified Screening for Squamous?Cell?Skin Cancer. J Invest Dermatol. 2018 12; 138(12):2589-2594.
    View in: PubMed
    Score: 0.015
  33. Lowenstein SE, Garrett G, Toland AE, Jambusaria-Pahlajani A, Asgari MM, Green A, Engels EA, Arron ST. Risk prediction tools for keratinocyte carcinoma after solid organ transplantation: a review of the literature. Br J Dermatol. 2017 Nov; 177(5):1202-1207.
    View in: PubMed
    Score: 0.015
  34. Mansh M, Binstock M, Williams K, Hafeez F, Kim J, Glidden D, Boettger R, Hays S, Kukreja J, Golden J, Asgari MM, Chin-Hong P, Singer JP, Arron ST. Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients. Am J Transplant. 2016 Jan; 16(1):262-70.
    View in: PubMed
    Score: 0.013
  35. Hoffmann TJ, Sakoda LC, Shen L, Jorgenson E, Habel LA, Liu J, Kvale MN, Asgari MM, Banda Y, Corley D, Kushi LH, Quesenberry CP, Schaefer C, Van Den Eeden SK, Risch N, Witte JS. Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort. PLoS Genet. 2015 Jan; 11(1):e1004930.
    View in: PubMed
    Score: 0.012
  36. Gamba CA, Swetter SM, Stefanick ML, Kubo J, Desai M, Spaunhurst KM, Sinha AA, Asgari MM, Sturgeon S, Tang JY. Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: the Women's Health Initiative. Cancer. 2013 Apr 15; 119(8):1562-9.
    View in: PubMed
    Score: 0.011
  37. Paulson KG, Iyer JG, Blom A, Warton EM, Sokil M, Yelistratova L, Schuman L, Nagase K, Bhatia S, Asgari MM, Nghiem P. Systemic immune suppression predicts diminished Merkel cell carcinoma-specific survival independent of stage. J Invest Dermatol. 2013 Mar; 133(3):642-646.
    View in: PubMed
    Score: 0.010
  38. Brasky TM, Potter JD, Kristal AR, Patterson RE, Peters U, Asgari MM, Thornquist MD, White E. Non-steroidal anti-inflammatory drugs and cancer incidence by sex in the VITamins And Lifestyle (VITAL) cohort. Cancer Causes Control. 2012 Mar; 23(3):431-44.
    View in: PubMed
    Score: 0.010
  39. Harris JN, Hay J, Kuniyuki A, Asgari MM, Press N, Bowen DJ. Using a family systems approach to investigate cancer risk communication within melanoma families. Psychooncology. 2010 Oct; 19(10):1102-11.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)